These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 29533752
41. American College of Rheumatology/European League Against Rheumatism remission criteria for rheumatoid arthritis maintain reliable performance when evaluated in 44 joints. Kaneko Y, Kondo H, Takeuchi T. J Rheumatol; 2013 Aug; 40(8):1254-8. PubMed ID: 23772077 [Abstract] [Full Text] [Related]
45. Early clinical response and long-term radiographic progression in recent-onset rheumatoid arthritis: Clinical remission within six months remains the treatment target. Legrand J, Kirchgesner T, Sokolova T, Vande Berg B, Durez P. Joint Bone Spine; 2019 Oct; 86(5):594-599. PubMed ID: 30928534 [Abstract] [Full Text] [Related]
46. Prognostic markers of clinical remission in early rheumatoid arthritis after two years of DMARDs in a clinical setting. Vázquez I, Graell E, Gratacós J, Cañete JD, Viñas O, Ercilla MG, Gómez A, Hernández MV, Rodríguez-Cros JR, Larrosa M, Sanmartí R. Clin Exp Rheumatol; 2007 Oct; 25(2):231-8. PubMed ID: 17543147 [Abstract] [Full Text] [Related]
47. Testing different thresholds for patient global assessment in defining remission for rheumatoid arthritis: are the current ACR/EULAR Boolean criteria optimal? Studenic P, Felson D, de Wit M, Alasti F, Stamm TA, Smolen JS, Aletaha D. Ann Rheum Dis; 2020 Apr; 79(4):445-452. PubMed ID: 32024651 [Abstract] [Full Text] [Related]
48. Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts. van der Woude D, Young A, Jayakumar K, Mertens BJ, Toes RE, van der Heijde D, Huizinga TW, van der Helm-van Mil AH. Arthritis Rheum; 2009 Aug; 60(8):2262-71. PubMed ID: 19644846 [Abstract] [Full Text] [Related]
49. Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort. Combe B, Rincheval N, Benessiano J, Berenbaum F, Cantagrel A, Daurès JP, Dougados M, Fardellone P, Fautrel B, Flipo RM, Goupille P, Guillemin F, Le Loët X, Logeart I, Mariette X, Meyer O, Ravaud P, Saraux A, Schaeverbeke T, Sibilia J. J Rheumatol; 2013 Oct; 40(10):1650-7. PubMed ID: 23950185 [Abstract] [Full Text] [Related]
50. Bilateral evaluation of the hand and wrist in untreated early inflammatory arthritis: a comparative study of ultrasonography and magnetic resonance imaging. Navalho M, Resende C, Rodrigues AM, Pereira da Silva JA, Fonseca JE, Campos J, Canhão H. J Rheumatol; 2013 Aug; 40(8):1282-92. PubMed ID: 23729806 [Abstract] [Full Text] [Related]
51. Prevalence of sustained remission in rheumatoid arthritis: impact of criteria sets and disease duration, a Nationwide Study in Sweden. Einarsson JT, Willim M, Ernestam S, Saxne T, Geborek P, Kapetanovic MC. Rheumatology (Oxford); 2019 Feb 01; 58(2):227-236. PubMed ID: 29538755 [Abstract] [Full Text] [Related]
52. Performance of the 2011 ACR/EULAR preliminary remission criteria compared with DAS28 remission in unselected patients with rheumatoid arthritis. Thiele K, Huscher D, Bischoff S, Späthling-Mestekemper S, Backhaus M, Aringer M, Kohlmann T, Zink A, German Collaborative Arthritis Centres. Ann Rheum Dis; 2013 Jul 01; 72(7):1194-9. PubMed ID: 22915625 [Abstract] [Full Text] [Related]
53. Frequency of remissions in early rheumatoid arthritis defined by 3 sets of criteria. a 5-year followup study. Mäkinen H, Kautiainen H, Hannonen P, Sokka T. J Rheumatol; 2005 May 01; 32(5):796-800. PubMed ID: 15868611 [Abstract] [Full Text] [Related]
54. Predictors of sustained remission in patients with early rheumatoid arthritis treated according to an aggressive treat-to-target protocol. Paulshus Sundlisæter N, Olsen IC, Aga AB, Hammer HB, Uhlig T, van der Heijde D, Kvien TK, Lillegraven S, Haavardsholm EA, ARCTIC study group. Rheumatology (Oxford); 2018 Nov 01; 57(11):2022-2031. PubMed ID: 30053199 [Abstract] [Full Text] [Related]
58. Aiming for SDAI remission versus low disease activity at 1 year after inclusion in ESPOIR cohort is associated with better 3-year structural outcomes. Ruyssen-Witrand A, Guernec G, Nigon D, Tobon G, Jamard B, Rat AC, Vittecoq O, Cantagrel A, Constantin A. Ann Rheum Dis; 2015 Sep 01; 74(9):1676-83. PubMed ID: 24794151 [Abstract] [Full Text] [Related]
59. Revisiting the use of remission criteria for rheumatoid arthritis by excluding patient global assessment: an individual meta-analysis of 5792 patients. Ferreira RJO, Welsing PMJ, Jacobs JWG, Gossec L, Ndosi M, Machado PM, van der Heijde D, Da Silva JAP. Ann Rheum Dis; 2021 Mar 01; 80(3):293-303. PubMed ID: 33023964 [Abstract] [Full Text] [Related]
60. Defining erosive disease typical of RA in the light of the ACR/EULAR 2010 criteria for rheumatoid arthritis; results of the data driven phase. Knevel R, Lukas C, van der Heijde D, Rincheval N, Combe B, van der Helm-van Mil AH. Ann Rheum Dis; 2013 Apr 01; 72(4):590-5. PubMed ID: 23393145 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]